Implementation status of safety measures to prevent errors with non-oncologic methotrexate: surveys in community and hospital pharmacies.
Lea Domenica BrühwilerSimone J GreschDavid L B SchwappachPublished in: International journal of clinical pharmacy (2023)
Safety in relation to methotrexate in pharmacies relies mostly on staff instructions, which are considered weak measures. In light of the serious risk imposed on patients, pharmacies should set a focus on stronger IT-based measures that rely less on human performance.
Keyphrases
- healthcare
- end stage renal disease
- endothelial cells
- ejection fraction
- newly diagnosed
- high dose
- mental health
- primary care
- chronic kidney disease
- emergency department
- low dose
- prostate cancer
- peritoneal dialysis
- rectal cancer
- patient reported outcomes
- cross sectional
- induced pluripotent stem cells
- minimally invasive
- long term care
- pluripotent stem cells
- acute care